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Abstract 
 
Angiogenesis is a physiological process that involves the formation of new blood 
vessels. In the cancer growth process, angiogenesis acts by supplying nutrition and oxygen 
for the cancer cells, carries metabolic waste and biological end product of cancer cells. 
Therefore the spread of cancer cells to the surrounding cells and tissues is accelerated. The 
occurrence of angiogenesis shows a change in cancer cell status, from dormant to malignant. 
Cancer cells induce the formation of angiogenesis through the secretion of various growth 
factors such as Vascular Endothelial Growth Factor (VEGF) and basic Fibroblast Growth 
Factor (bFGF).Currently many people turn into treatment using natural materials. One of the 
natural materials used for cancer therapy is pegagan (Centella asiatica). In this research 25 
embryonated chicken eggs (ECE) were divided into five treatment groups. Treatment group I 
as the control received 60 ng bFGF, treatment group II received neither bFGF nor pegagan 
leaves (Centella asiatica) water extract, and  treatment groups III-V received 60 ng bFGF and  
C. asiatica leaves water extract of 75, 90 and 110 µg.  Nine days old ESE were inoculated with 
bFGF and extract at the same time and then were incubated at 38
o
C for three days to allow 
the formation of blood vessels in embryonated chicken egg chorioallantoic membrane.  
Observations were performed microscopically and macroscopically by counting the new 
blood vessels formed around paper disc. Analysis on VEGF expression were conducted to 
define the role of angiogenesis growth factor. Research results showed a significant 
difference of treatment with Centella asiatica water extract on the number of new blood 
vessels formed. Centella asiatica water extract at the dose of 110 µg was the highest in 
inhibiting the formation of new blood vessels. Centella asiatica water extract also inhibited the 
expression of VEGF. 
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INTRODUCTION 
 
Cancer becomes health problem 
worldwide, since the accelerating morbidity and 
mortality caused by disease progression. 
According to World Health Organization 
(WHO), each year 6.25 millions of people are 
afflicted with cancer. It is predicted that 9 
millions of people would die of cancer for the 
following 10 years (Malcolm, et al., 2008). 
Cancer growth denoted carcinogenesis, begin 
with the development of one cell into small 
colony resided in the same tissue. This small 
colony undergoes genetic changes which leads 
to abnormality then malignancy (Bernard, 
2000). 
Angiogenesis is a physiological 
process that involves the formation of new 
blood vessels. Angiogenesis acts by supplying 
nutrition and oxygen for the cancer cells, 
carries metabolic waste and biological end 
product of cancer cells. Therefore the spread of 
cancer cells to the surrounding cells and tissues 
is accelerated. The occurrence of angiogenesis 
shows a change in cancer cell status, from 
dormant to malignant. Cancer cells induce the 
angiogenesis through the secretion of various 
growth factors such as vascular endothelial 
growth factor (VEGF) and basic fibroblast 
growth factor (bFGF) (Baker, 2007). 
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Basically, cancer treatment using 
chemotherapy or herbal medicines are not much 
different. Both treatments are effective to kill 
intracellular and extracellular cancer, which 
spread along the blood stream. Hitherto, cancer 
treatment by directly killing cancer cells is 
considered to be less effective because 
carcinogenic subtituents of cells are still able to 
spread freely to other tissues en route blood 
vessels. Therefore, cancer treatment by 
inhibiting angiogenesis is more effective in 
treating the disease than to kill the cancer cells 
directly. Via angiogenesis inhibition, the supply 
of nutrients and oxygen to cancer cells will be 
hampered thoroughly, thus resulted in growth 
inhibition of cancer (Rafii, 2002). Current trend 
presented societal preference toward natural 
ingredients. One of the natural ingredient that 
provides novelty for cancer treatment is 
pegagan (Centella asiatica). Previous studies of 
Centella asiatica with asiatic acid as the active 
compound recommended the application of this 
plant in the prevention and treatment of cancer 
(Ruan, 2006; Zheng, 2007). Angiogenesis is 
contributed to cancer carcinogenesis in the 
early development of disease. Then, this is the 
aim of this research to evaluate the role of 
Centella asicatica to influence angiongenesis.  
MATERIALS AND METHOD 
Sample Preparation 
Fresh leaves of Centella asiatica were 
washed thoroughly with flow water, drained, 
and dried by exposing indirectly to the sun heat 
(covered with dark cloth). The sun-dried leaves 
were then blended and shieved into fine 
powder. As many as 5 g of powders was put 
into a glass beaker, then added distilled water 
with a temperature of 28
o
C to reach a volume of 
200 mL. This process was carried out in an 
incubator for 24 hours. After that, the mixture 
was filtered with Whatmann paper no. 4 in 
order to get the water extract. The extract was 
then dried with a freeze dryer and stored in a 
refrigerator with a temperature of 10
o
C. 
Chemical 
Water extract of Centella asiatica was 
dissolved in aquadest for test purpose. 
Angiogenic inductor used in this research was 
human recombinant bFGF 10ng/µL. Nine days 
old   of   embryonated    chicken    eggs   (ECE)  
 
specific pathogenic free were used in incubated 
condition. The 0.01 M Tris-HCl pH 7.5 was 
used as bFGF solvent. 10 % phosphate buffered 
formalin used to preserve CAM membranes.  
Anti-angiogenic Assay 
Anti-angiogenic assay was performed 
on 9 days old ECE chorioallantoic membrane 
(CAM). A hole was drilled gently on the 
surface of ECE shell to form a rectangular area 
with 1 cm
2
 in width. Through this hole the test 
solution was implanted using media paper disc 
(Ribbati, et al., 2007). ECE were divided into 7 
groups, each treatment was consisted of five 
ECE. Treatment I: positive control, 60 ng bFGF 
administration. Treatment II: negative control, 
solvent (Tris-HCl and aquadest) administration. 
Treatment III: 60 ng bFGF and 75 µg water 
extract of Centella asiatica in aquadest. 
Treatment IV: 60 ng bFGF and 90 µg water 
extract of Centella asiatica in aquadest. 
Treatment V: 60 ng bFGF and 110 µg water 
extract of Centella asiatica in aquadest. 
Treatment VI: positive control group of 
synthetic antiangiogenesis drug 20 µg 
Celecoxib and 60 ng bFGF administrations. 
Treatment VII: negative group, 110 µg water 
extract of Centella asiatica in aquadest. After 
administrated with each treatment, ECEs were 
incubated in 38–39
o
C with 60% relative 
humidity for 72 hours. The ECE were then 
opened, removed egg contents gently to keep 
CAMs remain intacted to the eggshell. New 
blood vessels around the paper discs were 
counted. To observe the number of VEGF 
expression, immunohistochemistry was 
performed. The CAMs around paper discs were 
collected in 10% buffered formalin for HE 
staining.  
Data Analysis 
The number of microscopic and 
macroscopic new blood vessels formed during 
observation were analyze using parametric 
analysis of variance F-test. To compare the 
differences of means among each treatment 
group, Duncan multiple comparison test with 
95% confidence interval was employed. Using 
statistical software SPSS
TM
 version 16.0 
descriptive analysis of VEGF expression was 
conducted by comparing the results of 
imunohistochemical staining techniques from 
each treatment group. 
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RESULTS AND DISCUSSION 
 
The results of macroscopic observation 
and comparison between bFGF control group 
untreated with extract and group treated with 
extract were shown in Fig.1. Observations were 
followed by counting the number of new blood 
vessels or capillaries that extend and branch out 
from great vascular origin. The results of the 
calculation were presented as means of four 
replications from each treatment group. The 
means values of the number of new blood 
vessels can be seen in Table I. There was no 
significant difference in the number of blood 
vessels reduction for each concentration. The 
difference of means for each treatment was 
analyzed using Duncan multiple range test. The 
lowest means value of the number of blood 
vessels was 110 µg of Centella asiatica water 
extract + 60 ng bFGF treatment group, with the 
value of 2.60
c 
± 1.14. These results were not 
different significantly (p>0.05) with Tris 
solvents and DMSO control group, with the 
value of 3.20 ± 0.83. It indicates that 110 µg of 
Centella asiatica water extract has equal 
activity with solvent control group to inhibit the 
development of new blood vessels induced by 
60 ng bFGF. The 75 µg and 90 µg of Centella 
asiatica water extract treatment group were not 
different significantly. Nevertheless, the 
treatment groups showed inhibition activity 
toward new blood vessels development (4.00
bc
 
± 0.70; 4.40
b
 ± 1.51; 2.60
c
 ± 1.14) compared to 
60 ng bFGF control group (7.00
a
 ± 1.22). The 
20 µg celecoxib positive control group gave 
means value as much as 2.80
c
 ± 0.84, it was not 
different significantly compared to 110 µg of 
Centella asiatica water extract treatment group. 
The administration of Centella asiatica 
water extract for each group showed dose 
dependent manner. These results indicate that 
the higher concentration of Centella asiatica 
water extract will resulted in lower 
development of new blood vessels. The 
percentage of new blood vessels reduction for 
each treatment group is listed in Table 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The development of blood vessels around paper disc that was placed directly on the CAM. 
Two images above are bFGF control group untreated with extract. Lower left and lower right images 
are the group treated with 90 µg of extract and 110 µg of extract, respectively. 
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Table I.  The means values of the number of new blood vessels on CAM from each treatment group 
based on macroscopic observation 
Treatment groups 
The number of new blood vessels 
(Means ± SD) 
60 ng bFGF control 7.00a ± 1.22 
Tris and DMSO solvent control 3.20bc ± 0.83 
Treatment II : 75 µg of Centella asiatica extract + 60 ng bFGF 4.40b ± 1.51 
Treatment III : 90 µg of Centella asiatica extract + 60 ng 
bFGF 
4.00bc ± 0.70 
Treatment IV : 110 µg of Centella asiatica extract + 60 ng 
bFGF 
2.60c ± 1.14 
Positive control :  60 ng bFGF + 20 µg Celecoxib  2.80c ± 0.84 
Negative control : 110 µg Centella asiatica extract 3.40bc ± 0.54 
 
 
Table 2 . The percentage of new blood vessels reduction in CAM compared to the bFGF control  
group 
Treatment groups 
Percentage of blood vessels 
reduction  
(%) 
60 ng bFGF control ---  
Tris and DMSO solvent control 54.28 
Treatment II : 75 µg of Centella asiatica extract + 60 ng bFGF  37.14 
Treatment III : 90 µg of Centella asiatica extract + 60 ng bFGF 42.85 
Treatment IV : 110 µg of Centella asiatica extract + 60 ng bFGF 62.85 
Positive control :  60 ng bFGF + 20 µg Celecoxib  60.00 
Negative control : 110 µg Centella asiatica extract 51.30 
 
 
The highest value in the percentage of 
new blood vessels reduction was 110 µg of 
Centella asiatica water extract + 60 ng bFGF 
treatment group, with the value of 62.85%. This 
was not different significantly (p>0.05) 
compared to Tris-HCl and DMSO solvent 
control group (54.28%). Whereas 75 µg and 90 
µg of Centella asiatica water extract treatment 
group showed percentage of new blood vessels 
reduction, with the value of 37.14% and 
42.85%, respectively. Both treatments were not 
different significantly. Almost all treatment 
groups achieved percentage of new blood 
vessels reduction in average above 40%, 
indicating the success of Centella asiatica leaf 
extracts to inhibit the development of new 
blood vessels (angiogenesis). 
Microscopic observation toward blood 
vessels formation on CAM is necessary in order 
to validate macroscopic observation. This 
observation was carried out by calculating the 
formation of new blood vessels around the 
major veins. Conducted on three point of views, 
the means values were then calculated, results 
can be seen in Table 3. 
 
 
Table 3. The means values of the number of new blood vessels on CAM from each treatment group 
based on microscopic observation 
Treatment groups 
The number of new blood vessels 
(Means ± SD) 
60 ng bFGF control 93.77a ± 6.51 
Tris and DMSO solvent control 36.28c ± 2.71 
Treatment II : 75 µg of Centella asiatica extract + 60 ng bFGF  55.72b ± 5.72 
Treatment III : 90 µg of Centella asiatica extract + 60 ng bFGF 48.62b ± 8.95 
Treatment IV : 110 µg of Centella asiatica extract + 60 ng bFGF 51.06b ± 11.59 
Positive control :  60 ng bFGF + 20 µg Celecoxib  39.20c ± 2.38  
Negative control : 110 µg Centella asiatica extract 36.60c ± 5.03  
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Microscopic calculation of new blood 
vessels formation on CAM showed 
significant difference on means value for each 
Centella asiatica extract treatment group (75, 
90, and 110 µg), but not highly significant 
(p<0.01). Compared to solvent control group, 
there is no significant difference on means 
value of Centella asiatica extract treatment 
group (p>0.05). Nevertheless, the results 
showed that Centella asiatica water extract 
successfully inhibit the formation of new 
blood vessels induced by 60 ng bFGF. 
Histopathologic image of new blood vessel 
formation showed cross-sectional capillaries 
formed amidst CAM. Result can be seen in 
Fig. 2. 
Microscopically, new blood vessels 
denoted as blood vessels that grow and evolve 
from main veins. They are characterized by 
round to oval lumens, vascular walls 
resemblance to thin membranes, homo-
genous, unaccompanied by another muscles, 
and have rarely visible endothelial nuclei and 
blood cells in its lumen. The formation of 
new blood vessels presented in Fig. 2 were 
shown on the tip of the black arrow. 
Reduction in capillary blood vessels density 
was observed on each treatment. Newly 
formed blood vessels begin to decrease 
progressively by increasing concentration of 
Centella asiatica water extract.  
VEGF expression is present on 
endothelial cells of new blood vessels, which 
branch out from main veins. This new blood 
vessels usually appear around the main veins. 
VEGF expression in cytoplasm or on the 
surface of endhotelial cells can be detected 
using anti-VEGF antibody. The 
administration of 60 ng bFGF in treatment 
group resulted in VEGF expressions which 
were dominated by the presence of brown 
color. The reduction in brown color which 
indicate a lower expression of VEGF was 
shown after the administration of Centella 
asiatica water extract. This phenomenon was 
appear in dose dependent manner. The result 
from microscopic observation of VEGF 
expression is presented in Fig. 3. 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Cross-sectional capillaries formation on CAM for each treatment group, microscope with 
400x magnification. (A) bFGF positive control, (B) solvent control, (C) 75 µg extract + bFGF, (D) 90 
µg extract + bFGF, (E) 110 µg extract + bFGF. The arrow (          ) showed the formation of new blood 
vessels. 
 
(A) (B) (C) 
(D) (E) 
Hamid, et al., 2013 
Indones. J. Cancer Chemoprevent., 4(1), 463-469  
 
468 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. VEGF expressions in the treatment group are indicated by black arrows. (A) bFGF positive 
control without Centella asiatica extract, (B) solvent negative control, (C) 75 µg of Centella asiatica water 
extract treatment group, and (D) 110 µg of Centella asiatica water extract treatment group. 
 
 
Active compounds in Centella asiatica 
water extract are responsible in its anti-
angiogenesis activity. These active compounds 
comprising triterpenoids, for instances aglycone 
asiatic acid, madecassoside, and madasiatic 
acid. The vascular effect of triterpenoids is 
related to inhibition of collagen production. 
Collagen has an important role in the wound 
healing process by improving vascular 
endothelial (Gohil, et al., 2010). Among these 
tritepenoids, aglycon asiatic acid is dominant to 
inhibit the expression of angiogenic factor 
VEGF. It is in accordance with the research 
conducted by Kavitha, et al. (2011) that 5-20 
µM of asiatic acid inhibits stimulation factor for 
VEGF expression and formation of capillary 
tubes. Based on this study, it is concluded that 
Centella asiatica water extract inhibits the 
growth of new blood vessels on CAM induced 
by bFGF as the result of microscopic and 
macroscopic observations, and can inhibit the 
expression of VEGF. As many as 110 µg of 
Centella asiatica water extract provide highest 
barrier for the formation of new blood vessels. 
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